Nexalin Technology Has Received A Notice Of Allowance For Its U.S. Patent Application 18/342,590 Titled "Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) Method For Alzheimers And Dementia"
Nexalin Technology Has Received A Notice Of Allowance For Its U.S. Patent Application 18/342,590 Titled "Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) Method For Alzheimers And Dementia"
Nexalin Technology已收到批准其美國專利申請18/342,590的通知，該專利名爲 “治療阿爾茨海默氏症和癡呆症的經顱交流電動態頻率刺激（TACS）方法”
Nexalin Technology Has Received A Notice Of Allowance For Its U.S. Patent Application 18/342,590 Titled "Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) Method For Alzheimers And Dementia"
Nexalin Technology已收到批准其美國專利申請18/342,590的通知，該專利名爲 “治療阿爾茨海默氏症和癡呆症的經顱交流電動態頻率刺激（TACS）方法”
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。